Lataa...
Health Canada's use of its priority review process for new drugs: a cohort study
OBJECTIVES: Priority reviews of new drug applications are resource intensive and drugs approved through this process have a greater likelihood of acquiring a serious safety warning compared to drugs approved through the standard process. Therefore, when Health Canada uses priority reviews, it is imp...
Tallennettuna:
| Julkaisussa: | BMJ Open |
|---|---|
| Päätekijä: | |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
BMJ Publishing Group
2015
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4431066/ https://ncbi.nlm.nih.gov/pubmed/25967989 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bmjopen-2014-006816 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|